Study of SOX combined with intraperitoneal high‐dose paclitaxel in gastric cancer with synchronous peritoneal metastasis: A phase II single‐arm clinical trial

BACKGROUND: Intraperitoneal paclitaxel is proved to be efficient for peritoneal metastasis of gastric cancer. It remains uncertain the efficacy and safety of the triplets regimen which combined intraperitoneal high‐dose paclitaxel with systemic SOX in gastric cancer patients with peritoneal metastas...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Li, Zhang, Weihan, Ni, Lu, Xu, Zihan, Yang, Kun, Gou, Hongfeng, Zhu, Qing, Liu, Ming, Yang, Yu, Hu, Jiankun, Qiu, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972103/
https://www.ncbi.nlm.nih.gov/pubmed/36161282
http://dx.doi.org/10.1002/cam4.5277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972103/
https://www.ncbi.nlm.nih.gov/pubmed/36161282
http://dx.doi.org/10.1002/cam4.5277

Ejemplares similares